
will
85 posts

will
@thewillomeara
Head of comedic alignment research









Today, we announce our most long-awaited offering — Superpower Peptides. For too long, Americans seeking access to peptides have been left with two options: go without, or turn to unregulated sources that put their health at risk. That's beginning to change. And we've been building for this moment. Introducing Superpower Peptides: • Pure. Third-party tested • Rigorously sourced • Backed by science As the FDA moves to restore regulated access to 12 key peptides we'll be here, ready. Existing members get early access today. Others can reserve their username on our waitlist: 👉 superpower . com / peptides The peptide era begins



Today, we took long-overdue action to restore science, accountability, and the rule of law. In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk. Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence. • BPC-157 • Thymosin beta-4 fragment (LKKTETQ) • Epitalon • GHK-Cu (injectable) • MOTS-c • DSIP (Emideltide) • Dihexa Acetate • Ibutamoren Mesylate • Melanotan II • KPV • Semax (heptapeptide) • Cathelicidin LL-37 This action begins to restore regulated access and will immediately begin shifting demand away from the black market. We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.

My thoughts on peptides…
























